Chest Imaging, Breath, and Biomarkers in a Screening Trial

NCT ID: NCT01663155

Last Updated: 2017-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1424 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-09-30

Study Completion Date

2014-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The fight against lung cancer is waged on three major fronts: prevention, detection and treatment. Our goal is to determine if chest x-rays,computer aided detection (CAD)and a CT scan can detect disease earlier when treatment is more effective. If we improve the detection of disease, we will see if screening reduces the incidence of symptomatic advanced lung cancer relative to no screening in people at high risk to develop lung cancer.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

all enrolled subjects

Intervention is chest x-ray and CT scan. The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader. Subjects are asked to contribute breath and blood samples.

chest x-ray with or without CAD, lose dose CT scan

Intervention Type DEVICE

PA view, low dose CT scan

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

chest x-ray with or without CAD, lose dose CT scan

PA view, low dose CT scan

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

CAD computer aided detection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ages 40-75 years
* If ages 40-59, then one of the following criteria needs to be met:

* Current or ex-smoker with \>25 pack years and a family history of lung cancer(parent or sibling) OR
* current or ex-smoker with \> 25 pack years and COPD OR
* current or ex-smoker with a \> 35 pack year history
* If ages 60-75, then one of the following additional criteria needs to be met:

* Current or ex-smoker with \>25 pack years and a family history of lung cancer (parent or sibling) OR
* Current or ex-smoker with \>25 pack years and COPD OR
* Current or ex-smoker with a \>30 pack year history
* Subject is able to return to Cleveland Clinic for annual follow-up screening
* Subject is willing to sign a medical release form

Exclusion Criteria

* Current health requires oxygen
* Have had a chest x-ray or CT of the chest within the last 6 months
* Previous pneumonectomy
* Lobectomy of the lung within the last 5 years
* Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer
* A medical condition that would prevent treatment for lung cancer
* Within the last 6 weeks, one of the following has occured:

* A new cough or chronic cough that has gotten worse
* Either new shortness of breath, or any worsening of shortness of breath
* A cough producing blood
* Constant chest pain
* Respiratory infection, pneumonia, or cold
* Unintentional and unexplained weight loss greater than 5% of total body weight
Minimum Eligible Age

40 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Cleveland Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Moulay Meziane, MD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Micheal Phillips, M.D.

Role: STUDY_CHAIR

The Cleveland Clinic

Moulay Meziane, MD

Role: PRINCIPAL_INVESTIGATOR

Chair of Thoracic Imaging

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Mazzone PJ, Obuchowski N, Fu AZ, Phillips M, Meziane M. Quality of life and healthcare use in a randomized controlled lung cancer screening study. Ann Am Thorac Soc. 2013 Aug;10(4):324-9. doi: 10.1513/AnnalsATS.201301-007OC.

Reference Type DERIVED
PMID: 23952850 (View on PubMed)

Mazzone PJ, Obuchowski N, Phillips M, Risius B, Bazerbashi B, Meziane M. Lung cancer screening with computer aided detection chest radiography: design and results of a randomized, controlled trial. PLoS One. 2013;8(3):e59650. doi: 10.1371/journal.pone.0059650. Epub 2013 Mar 20.

Reference Type DERIVED
PMID: 23527241 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

State of Ohio grant

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

06-055

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

07-455

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lung Screening Study
NCT00006382 COMPLETED NA
Early Detection of Lung Cancer
NCT03181256 ACTIVE_NOT_RECRUITING